| | If you're having trouble viewing this email, click here | | | | Bronchial Thermoplasty for the Treatment of Severe Asthma | For these people with severe asthma, there needs to be another type of therapy for those who don’t seem to respond to typical asthma medications. Bronchial thermoplasty (BT) is a non-pharmacologic therapy indicated for the treatment of severe asthma for people who don’t respond well to the usual asthma medications. BT was approved by the U.S. Food and Drug Administration in 2010 for the treatment of severe asthma in patients 18 years and older whose symptoms were not controlled despite usual asthma therapies. | | Daniel More, MD Allergies Expert | | | All About Bronchial Thermoplasty | Bronchial thermoplasty utilizes thermal energy (heat) on the smooth muscle inside the airways of the lungs. It is this smooth muscle that is enlarged (hypertrophy) and more abundant (hyperplasia) in the lungs of severe asthmatics. The contraction of this muscle is what is responsible for asthma symptoms, and what inhaled medicines for asthma are supposed to relax (bronchodilators) and prevent further symptoms (inhaled steroids). | | | All About Severe Asthma | Patients are frequently referred to me with severe asthma that is difficult to control despite numerous asthma medications. Asthma medications are so effective nowadays, that when patients have uncontrolled asthma even though they are taking multiple asthma controllers, there is reason for concern. The following are the most common reasons that I find why patients have difficult-to-control asthma. | | | All About Xolair for Difficult to Control Asthma | Xolair (omalizumab) is an injectable medication used to treat moderate to severe allergic asthma. It can be used in people 12 years and older who still have uncontrolled asthma despite typical asthma medications, such as inhaled steroids. Xolair is a monoclonal anti-IgE antibody, which binds to IgE in the bloodstream, allowing the body to remove them. Xolair has been shown to decrease asthma attacks, improve spirometry values, improve overall quality of life for people with asthma, and reduce the amount of corticosteroids needed. | | | | | | You are receiving this newsletter because you subscribed to the Allergies newsletter. If you wish to unsubscribe, please click here | | 1500 Broadway, 6th Floor, New York, NY, 10036 | | | | | | | | |
No comments:
Post a Comment